Reference Guide for Integrating Continuous Glucose Monitoring Into Clinical Practice
Abstract
Purpose: Large randomized trials have demonstrated the efficacy of continuous glucose monitoring (CGM) in persons with type 1 diabetes and insulin-treated type 2 diabetes. The purpose of this article is to provide basic knowledge about CGM technology, discuss the use of CGM data in clinical practice, and direct clinicians to online resources that provide comprehensive information and tools relevant to patient selection, education/training, and reimbursement. Conclusions: Effective use of CGM requires all members of the health care team to become knowledgeable and skilled in integrating CGM into their practices and in teaching their patients how to safely incorporate CGM use into their daily diabetes self-management.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Retrospective analysis of CGM data, utilizing standardized data management tools such as the AGP, enables clinicians and people with diabetes to work collaboratively in identifying problem areas and then set achievable goals.
“Retrospective analysis of CGM data, utilizing standardized data management tools such as the AGP, enables clinicians and people with diabetes to work collaboratively in identifying problem areas and then set achievable goals (71-73).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [72]
Cites
International consensus on use of continuous glucose monitoring
Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1600 · Cited by 2,069 · see citing works
Self-citationBeck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · see citing works
Self-citationBolinder, J., Antuna, R., Geelhoed-Duijvestijn, P., Kröger, J., & Weitgasser, R. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31535-5 · Cited by 893 · see citing works
Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring
Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., Brown, A. S., Heinemann, L., Aleppo, G., Ryan, D. B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1581 · Cited by 684 · see citing works
Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2855 · Cited by 635 · see citing works
Self-citationHeinemann, L., Freckmann, G., Ehrmann, D., Faber-Heinemann, G., Guerra, S., Waldenmaier, D., & Hermanns, N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30297-6 · Cited by 522 · see citing works
Bergenstal, R. M., Ahmann, A. J., Bailey, T., Beck, R. W., Bissen, J., Buckingham, B., Deeb, L., Dolin, R. H., Garg, S. K., Goland, R., et al. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0051 · Cited by 307 · see citing works
Reddy, M., Jugnee, N., El Laboudi, A., Spanudakis, E., Anantharaja, S., & Oliver, N. (2018) · Diabetic Medicine · doi:10.1111/dme.13561 · Cited by 245 · see citing works
Fonseca, V. A., Grunberger, G., Anhalt, H., Bailey, T. S., Blevins, T., Garg, S. K., Handelsman, Y., Hirsch, I. B., Orzeck, E. A., Roberts, V. L., et al. (2016) · Endocrine Practice · doi:10.4158/ep161392.cs · Cited by 195 · see citing works
Šoupal, J., Petruželková, L., Flekač, M., Pelcl, T., Matoulek, M., Daňková, M., Škrha, J., Svačina, Š., & Prázný, M. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0171 · Cited by 126 · see citing works
Laffel, L. M., Aleppo, G., Buckingham, B. A., Forlenza, G. P., Rasbach, L. E., Tsalikian, E., Weinzimer, S. A., & Harris, D. R. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2017-00389 · Cited by 79 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,032 · see citing works
Self-citationContinuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology
Galindo, R. J., & Aleppo, G. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108502 · Cited by 138 · see citing works
Johnson, M. L., Martens, T. W., Criego, A. B., Carlson, A. L., Simonson, G. D., & Bergenstal, R. M. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0034 · Cited by 104 · see citing works
“53 Retrospective analysis of CGM data using AGP, from real-time or masked CGM data, presents a more complete picture of glycemic management, providing critical metrics such as TIR, allowing evaluation of glycemic variability, and displaying glycemic patterns.”
The competitive athlete with type 1 diabetes
Riddell, M. C., Scott, S. N., Fournier, P. A., Colberg, S. R., GALLEN, I. W., Moser, O., Stettler, C., Yardley, J. E., Zaharieva, D. P., Adolfsson, P., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05183-8 · Cited by 104 · see citing works
Joseph, J. I. (2020) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820911919 · Cited by 72 · see citing works
Wearable Healthcare and Continuous Vital Sign Monitoring with IoT Integration
Taherdoost, H. (2024) · Computers, Materials & Continua · doi:10.32604/cmc.2024.054378 · Cited by 47 · see citing works
Cowart, K., Updike, W., & Bullers, K. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0345 · Cited by 36 · see citing works
Ridder, F. D., den Brinker, M., & Block, C. E. M. D. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819871903 · Cited by 29 · see citing works
Matabuena, M., Pazos-Couselo, M., Alonso‐Sampedro, M., Fernández‐Merino, C., González‐Quintela, A., & Gudé, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-40949-1 · Cited by 26 · see citing works
“These devices can be used in the “blinded” mode to capture information about what patients are doing without influencing their behavior 2 .”
BackgroundPractical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care
Unger, J., Kushner, P. R., & Anderson, J. E. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1744393 · Cited by 27 · see citing works
Time above range for predicting the development of type 2 diabetes
Marco, A., Pazos-Couselo, M., Moreno-Fernández, J., Díez‐Fernández, A., Alonso‐Sampedro, M., Fernández‐Merino, C., González‐Quintela, A., & Gudé, F. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1005513 · Cited by 21 · see citing works
“The clinical utility of retrospective data analysis is to identify offtarget glucose patterns, determine potential causes, and discuss possible solutions (46).”
BackgroundRidder, F. D., den Brinker, M., & Block, C. E. M. D. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819865399 · Cited by 22 · see citing works
Frank, J., Blissett, D. B., Hellmund, R., & Virdi, N. S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0263 · Cited by 23 · see citing works
“27 Importantly, CGM devices alert patients when glucose levels are crossing above or below safe glucose thresholds.”
Utilizing continuous glucose monitoring in primary care practice: What the numbers mean
Edelman, S. V., Cavaiola, T. S., BOEDER, S. C., & Pettus, J. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.10.013 · Cited by 25 · see citing works
Self-citationPatient Perspectives on the Benefits and Challenges of Diabetes and Digital Technology
Edelman, S. V., Cheatham, W. W., Norton, A., & Close, K. L. (2023) · Clinical Diabetes · doi:10.2337/cd23-0003 · Cited by 18 · see citing works
“This functionality ultimately reduces the risks of hyperglycemia and hypoglycemia and over the long term, can lead to better heart, liver, and kidney health by helping to prevent diabetes-related complications (23,25 – 27).”
BackgroundMethodSelf-citationSimonyan, A. R., Isaacs, D. M., Lekic, S., Blanchette, J. E., Noe, D. R., & Galloway, N. R. (2021) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1409 · Cited by 11 · see citing works
“A transmitter is attached and communicates to a receiver or reader.(9) This allows for assessment of glucose patterns based on one's unique response to food, exercise, medications, and stress.”
BackgroundInfluentialCowart, K. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819890865 · Cited by 8 · see citing works
“Continuous glucose monitoring (CGM) is an alternative to self-monitoring of blood glucose (SMBG) and allows patients with diabetes to react to glycemic patterns, which can inform meal intake, physical activity, carbohydrate counting, and medication adjustments.(1) As compared with SMBG, real-time CGM (rtCGM) and inter…”
BackgroundWysham, C., & Kruger, D. F. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab064 · Cited by 6 · see citing works
“A recent publication by Kruger et al provides comprehensive recommendations for integrating CGM use in clinical practices [34].”
MethodSelf-citationIntegration of Diabetes Technology in Clinical Practice
Peters, A. L. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.10.002 · Cited by 8 · see citing works
Handling Missing Data in CGM Records
Zulj, S., Carvalho, P., Ribeiro, R., & Magjarević, R. (2019) · IFMBE Proceedings · doi:10.1007/978-3-030-30636-6_57 · Cited by 6 · see citing works
Continuous Glucose Monitors as Wearable Lifestyle Behavior Change Tools in Obesity and Diabetes
Schembre, S. M., Liao, Y., & Jospe, M. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_43 · Cited by 8 · see citing works
Wiggins, K. T., Hall, T. L., Jortberg, B. T., Dickinson, W. P., Dickinson, L., Parascando, J., Fernald, D. H., Sobczak, C., Oser, S., & Oser, T. K. (2025) · BMC Primary Care · doi:10.1186/s12875-025-02903-0 · Cited by 5 · see citing works
“CGM uses a sensor inserted subcutaneously for 7 to 15 days to continuously measure interstitial glucose levels, which reduces or eliminates the need for fingerstick glucose checks [9, 10].”
Mukheli, T., Fourie, A., Mokoena, T., Kagodora, S. B., & Luvhengo, T. (2025) · Diabetology · doi:10.3390/diabetology6040031 · Cited by 5
Hall, T. L., Dickinson, L. M., Warman, M. K., Oser, T. K., & Oser, S. M. (2024) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000001060 · Cited by 7 · see citing works
“…readings and visualizations of glucose levels, which can improve awareness of hypoglycemia, hyper-glycemia, and glucose variability and help patients and their health care team make increasingly informed decisions about dietary and medication regimens (Hermanns et al., 2019; Kruger et al., 2019).”
Parise, M., Molfetta, S. D., Graziano, R. T., Fiorentino, R., Cutruzzolà, A., Gnasso, A., & Irace, C. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20053945 · Cited by 7 · see citing works
“However, the meaning of the different arrows may vary depending on the manufacturer [5].”
BackgroundThe Changing Landscape of Glycemic Targets: Focus on Continuous Glucose Monitoring
Kushner, P., & Kruger, D. (2020) · Clinical Diabetes · doi:10.2337/figshare.12245486.v1 · Cited by 5 · see citing works
Self-citationBotelho, M. S., Galendi, J. S. C., Novo, M. A. F. M., & Nogueira, V. D. S. N. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01935-x · Cited by 5 · see citing works
“…immediate adjustments, especially when integrated with insulin pumps; however, it often involves higher costs and the need for periodic calibration [15]. isCGM measures glucose in the interstitial fluid and offers data through scanning with a reader or smartphone app, providing convenience and…”
Kongdee, R., Bijan Parsia, A., Thabit, H., & Harper, S. (2025) · Digital Health · doi:10.1177/20552076251332580 · Cited by 3 · see citing works
“…decisions approximately 180 times per day 3 to maintain their blood glucose within the clinically recommended range of 3.9 – 10.0 mmol/L. 4 5 – 8 However, their shortcomings have often been reported in research studies, especially problems associated with interpreting data hyperglycaemia.”
InfluentialJohansson, U., Gleissman, S. A., Liden, M. K., Wickman, M., Gustafsson, B. M., & Sjöberg, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29498 · Cited by 4 · see citing works
“This collaborative approach facilitates the identification of problematic areas and the establishment of achievable goals related to glucose control, treatment and self-care [11,12].”
BackgroundUse of continuous glucose monitoring to improve glycemic management: A clinician's guide
Schumacher, C., Isaacs, D. M., Collier, I. A., & Klinkebiel, D. (2020) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1295 · Cited by 7 · see citing works
Wang, R., Zhang, Y., Zeng, H., Xiao, J., Qi, M., Bao, L., Jiao, R., Liu, J., Li, Y.-C., He, S., et al. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/1021066 · Cited by 2 · see citing works
“It is increasingly recognized in clinical practice as a signi fi cant indicator of glucose control [5].”
Use of Retrospective Continuous Glucose Monitoring Data Is Underrated and Underused
Nguyen, Q., Iyyavoo, A. A., & Parkin, C. G. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211070837 · Cited by 3 · see citing works
Self-citationDeeb, A., Muammar, T., Alsaffar, H., Sedaghat, S., Hassani, N. A., Odeh, R., Alkhayyat, H., Sinani, A. A., Attia, N. A., Adhami, S., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108671 · Cited by 7 · see citing works
The pharmacist’s role in continuous glucose monitoring
Isaacs, D. M. (2020) · Pharmacy Today · doi:10.1016/j.ptdy.2020.04.014 · Cited by 5 · see citing works
Liu, P., Zeng, T., Cai, L., Wang, J., & Xue, L. (2021) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.spl.180 · Cited by 3 · see citing works
“The treatment method for type 2 diabetes mellitus is mainly hypoglycemic drug therapy[1-3].”
MethodAGP Reports for Glucose and Insulin Devices Qualitative Study: What Patients and Clinicians Want
Mullen, D. M., Bergenstal, R. M., Johnson, M. L., Cengiz, E., Criego, A. B., Deeb, L. C., Goland, R., Rudolph, J., Arnold, K. C., Kruger, D. F., et al. (2025) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106251337486 · Cited by 2 · see citing works
Self-citationMaines, E., Pertile, R., Cauvin, V., Soffiati, M., & Franceschi, R. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111720 · Cited by 2 · see citing works
Sehgal, S., Boucsein, A., Styles, S. E., Palmer, O., Paul, R. G., Crocket, H. R., de Bock, M. I., & Wheeler, B. J. (2023) · Diabetic Medicine · doi:10.1111/dme.15168 · Cited by 2 · see citing works
“All participants reported that they trusted in the DIY-CGM device to some degree despite experiencing some technical challenges (quote 24).”
BackgroundEmpowering People with Diabetes: Role of Continuous Glucose Monitor Systems
Srivastava, S. B. (2023) · American Journal of Lifestyle Medicine · doi:10.1177/15598276231158044 · Cited by 4 · see citing works
“of medication or self-care behavior changes.(5,6)”
Mateu-Salat, M., Moreno-Fernández, J., Mangas, N., Genua, I., Martínez, M. Á., López, A., González, C., & Chico, A. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.04.008 · Cited by 2 · see citing works
Flash Continuous Glucose Monitoring: A Practical Guide and Call to Action for Pharmacists
Cowart, K., & Zgibor, J. C. (2021) · Journal of Pharmacy Practice · doi:10.1177/08971900211000273 · Cited by 2 · see citing works
Patient Satisfaction and Clinical Experience With MiniMed 670G Hybrid Closed-Loop System
Meade, L. T. (2020) · ADCES in Practice · doi:10.1177/2633559x20938800 · Cited by 3 · see citing works
Cuenca, A. C. C., de la Cuadra-Grande, A., Martínez, E. A., Cabello, M. I. E., Cruz, N. M., Cambra, G. C., Hermida, Á. Á. Á., Navarro, J., Oyagüez, I., & de la Puente, J. B. (2026) · Primary Care Diabetes · doi:10.1016/j.pcd.2026.07.007 · Cited by 1 · see citing works
A Review on Continuous Glucose Monitoring (CGM): Perspectives on Glucose Biosensors
Srineela, B., Khan, S., Branham, S. K., & Pande, A. H. (2022) · International Journal of Health Technology and Innovation · doi:10.60142/ijhti.v1i02.42
Mateu-Salat, M., Moreno-Fernández, J., Mangas, N., Genua, I., Martínez, M., López, A., González, C., & Chico, A. (2022) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endien.2022.03.007
Primary Care and Diabetes Technologies and Treatments
Simonson, G., Martens, T. W., Carlson, A. L., & Bergenstal, R. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.2510
CGM-101: How to Identify Appropriate Use
Howell, C., & Meredith, A. H. (2020) · ADCES in Practice · doi:10.1177/2633559x20925456
- Authors
- Kruger, D. F., Edelman, S. V., Hinnen, D. A., & Parkin, C. G.
- Affiliations
- Henry Ford Health (US)
- University of California San Diego and Taking Control of Your Diabetes 501c3, San Diego, California
- University of Colorado Health (US)
- CGParkin Communications, Inc, Henderson, Nevada
- Corresponding author
- Parkin, Christopher G.
- Venue
- The Diabetes Educator
- Publisher
- SAGE Publications
- Published
- 2018-12-13
- Volume
- 45
- Issue
- 1_suppl
- Pages
- 3S-20S
- ISSN
- 0145-7217 (ISSN-L)
- 1554-6063
- OpenAlex
- W2904964246
- Cited by
- 55
- References
- 30
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 8 · 2020: 12 · 2019: 9
- FWCI
- 5.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Science of Diabetes Self-Management and Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Dexcom, Inc.
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, type 2 diabetes, insulin-treated diabetes, diabetes self-management, patient education, patient selection, reimbursement, health team training
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Humans, Blood Glucose Self-Monitoring, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
